However, due to concerns for safety, quality, and effectiveness of compounded GLP1RAs, the American Diabetes Association (ADA) has issued guidance recommending switching individuals to different FDA-approved medications to achieve and maintain individualized glucose-lowering, weight management, and/or cardiovascular and kidney risk reduction goals when supply or access is limited [75]
They aim to improve convenience, tissue penetration, and adherence compared to injectable forms
(2026 Physician Review) Tirzepatide Before and After Results: Weight Loss Timelines (2026)
Tirzepatide (Mounjaro, Zepbound, compounded) Tirzepatide is a dual GIP/GLP-1 receptor agonist, which means its mechanism differs slightly from pure GLP-1 medications
When you take a lifelong medication, you should also be closely monitored by a doctor who understands your health journey
If your goal is real GLP-1-level results, this is unlikely to be the substitute the marketing implies